Claudia N Montero-Menei Selected Research

Nerve Growth Factors (Neurotrophins)

2/2004	Long-term effect of intra-striatal glial cell line-derived neurotrophic factor-releasing microspheres in a partial rat model of Parkinson's disease.
2/2004	Striatal implantation of GDNF releasing biodegradable microspheres promotes recovery of motor function in a partial model of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudia N Montero-Menei Research Topics

Disease

7	Parkinson Disease (Parkinson's Disease) 06/2015 - 02/2004
4	Myocardial Infarction 12/2021 - 08/2012
4	Neoplasms (Cancer) 01/2019 - 09/2012
3	Huntington Disease (Huntington's Disease) 10/2019 - 10/2013
3	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 01/2015
3	Brain Neoplasms (Brain Tumor) 01/2017 - 04/2002
3	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2016 - 03/2004
2	Nervous System Diseases (Neurological Disorders) 01/2017 - 10/2013
2	Hypoxia (Hypoxemia) 03/2015 - 01/2013
2	Brain Ischemia (Cerebral Ischemia) 10/2013 - 12/2011
2	Glioma (Gliomas) 09/2012 - 04/2002
1	Spinal Cord Injuries (Spinal Cord Injury) 09/2020
1	Infections 01/2019
1	Residual Neoplasm 01/2019
1	Central Nervous System Diseases (CNS Diseases) 01/2017
1	Fibrosis (Cirrhosis) 10/2015
1	Ischemic Stroke 03/2015
1	Stroke (Strokes) 03/2015
1	Heart Arrest (Cardiac Arrest) 12/2011
1	Ischemia 12/2011
1	Wounds and Injuries (Trauma) 10/2006
1	Atrophy 10/2006
1	Multiple Sclerosis 05/2003
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2003

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 10/2019 - 09/2012
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 03/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2015 - 01/2013
3	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 03/2004 - 02/2004
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 09/2020 - 01/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017 - 03/2015
2	Nerve Growth Factors (Neurotrophins)IBA 02/2004 - 02/2004
1	AntioxidantsIBA 12/2021
1	Antiviral Agents (Antivirals)IBA 01/2019
1	Chemotactic FactorsIBA 01/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2017
1	HydrogelsIBA 01/2017
1	Nucleic AcidsIBA 03/2016
1	Biocompatible Materials (Biomaterials)IBA 03/2016
1	Insulin-Like Growth Factor I (IGF-1)IBA 09/2015
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 09/2015
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 09/2015
1	Insulin (Novolin)FDA Link 09/2015
1	Laminin (Merosin)IBA 03/2015
1	ferrociphenolIBA 01/2015
1	NanocapsulesIBA 01/2015
1	LipidsIBA 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 12/2011
1	Oxygen (Dioxygen)IBA 12/2011
1	PolymersIBA 10/2006
1	poly(methylidene malonate) 2.1.2IBA 10/2006
1	SuspensionsIBA 06/2006
1	Nitric Oxide Synthase (NO Synthase)IBA 05/2003
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 05/2003
1	Calcitriol (Calcijex)FDA LinkGeneric 05/2003
1	Vitamin D FDA LinkGeneric 05/2003
1	Hormones (Hormone)IBA 04/2002

Therapy/Procedure

10	Therapeutics 10/2019 - 12/2011
4	Transplantation 10/2019 - 06/2006
4	Microspheres (Microsphere) 10/2006 - 02/2004
1	Intravenous Injections 12/2021
1	Radiotherapy 01/2019
1	Injections 01/2017
1	Intranasal Administration 01/2017
1	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2007
1	Cell Transplantation 04/2007